Compare State Street SPDR S&P Biotech ETF (XBI) vs Roundhill S&P 500 0DTE Covered Call Strategy ETF (XDTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
State Street SPDR S&P Biotech ETF vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? State Street SPDR S&P Biotech ETF trades at $158.2, while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $39.45. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Roundhill S&P 500 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals.
| XBI | XDTE | |
|---|---|---|
Sector | Broad Market / Factor | Income / Options Overlay |
52-Week High | $164.28 | $44.76 |
52-Week Low | $86.92 | $36.00 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →About Roundhill S&P 500 0DTE Covered Call Strategy ETF
XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →
